“alnylam-pharmaceuticals” Archives

in
Entry Author Date Location
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms 05/20/19 New York
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
Alnylam Makes Case For 2nd RNAi Drug at Big Liver Disease Meeting 04/12/19 Boston
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More 04/12/19 National
Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases 04/08/19 Boston
Sanford Burnham Prebys, WARF Partner on Drug Discovery 03/25/19 San Diego
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
Data in Hand, Alnylam to Seek OK for Second RNAi Drug 03/06/19 Boston
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer 01/18/19 National
From Alnylam to Zayner: Xconomy’s Top Innovation Stories of 2018 12/27/18 National
Can Pay-For-Results Drug Pricing Work? A Q&A With Michael Sherman 12/19/18 Boston
15 For ’19: Key Clinical Data to Watch For Next Year (Part 2) 12/18/18 National
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO 12/07/18 National
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline 12/06/18 Raleigh Durham
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel 11/09/18 National
Bio Roundup: Depression Drug Dashed, Peek at ASH, CRISPR Worry & More 11/02/18 National
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug 10/15/18 Boston
FDA OKs Akcea Rare Disease Drug, Setting Up Market Clash with Alnylam 10/05/18 Boston
Janssen Reaches $250M Deal for Rights to Arrowhead’s Hep B RNAi Drug 10/04/18 Wisconsin
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom 10/04/18 San Francisco
Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More 09/28/18 National
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug 09/27/18 Boston
The Winners of the 2018 Xconomy Awards Are… 09/05/18 Boston
Bio Roundup: Pfizer’s Rare Results, U.K.’s CAR-T No, IPO Go-Go & More 08/31/18 National
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug 08/30/18 Boston
Eyeing Approval, Pfizer Touts Tafamidis Study, but Details Lacking 08/27/18 New York
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug 08/10/18 Boston
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More 08/10/18 National
Page 1 of 13 next page »